Overview

RapidAI's Neurovascular suite is a comprehensive AI-driven platform designed to enhance the diagnosis and management of cerebrovascular conditions, including ischemic stroke, hemorrhagic stroke, and cerebral aneurysms. By integrating advanced imaging analytics with real-time clinical decision support, it empowers healthcare professionals to make faster, more accurate decisions, ultimately improving patient outcomes.

Features and Capabilities

• Rapid ICH: AI-driven detection and volumetric assessment of intracranial hemorrhage (ICH) within minutes, supporting timely intervention.
• Rapid LVO: Automated identification of large vessel occlusions (LVOs) in CT angiography, facilitating rapid triage and treatment decisions.
• Rapid Aneurysm: 3D visualization and automated measurement of cerebral aneurysms, enabling precise monitoring and management.
• Rapid Hyperdensity: Quantification of hyperdense tissue in non-contrast CT scans to assess injury severity and guide treatment strategies.
• Rapid ASPECTS: Automated Alberta Stroke Program Early CT Score (ASPECTS) calculation to evaluate ischemic changes and thrombectomy eligibility.
• Rapid CTA: Creation of 3D vascular reconstructions from CT angiograms to assess vessel patency and plan interventions.
• Mobile Integration: Real-time notifications and access to imaging results via mobile devices, enhancing care coordination across teams.
• EMR Integration: Seamless integration with Electronic Medical Records (EMR) systems for streamlined workflow and documentation.
• Clinical Validation: Backed by extensive clinical studies and FDA clearances, ensuring reliability and accuracy in clinical settings.